Detalles de la búsqueda
1.
Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study.
Acta Oncol
; 63: 213-219, 2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38647024
2.
Biological Rationale for Peripheral Blood Cell-Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer.
Curr Oncol Rep
; 24(12): 1851-1862, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36255605
3.
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.
Future Oncol
; 18(23): 2593-2604, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35722877
4.
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
Int J Mol Sci
; 22(5)2021 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33807876
5.
Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy.
Future Oncol
; 15(23): 2743-2757, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31339060
6.
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs.
Tumori
; : 3008916241246659, 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38623748
7.
Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems.
Heliyon
; 10(1): e23914, 2024 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38234913
8.
The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project.
Cancer Med
; 13(9): e7159, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38741546
9.
Demographic Analysis of Cancer Research Priorities and Treatment Correlations.
Curr Oncol
; 31(4): 1839-1864, 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38668042
10.
Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis.
Healthcare (Basel)
; 12(2)2024 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38275541
11.
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 25(3): 233-243.e8, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38105153
12.
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research.
Clin Lung Cancer
; 25(2): 190-195, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262770
13.
223Ra-dichloride therapy in an elderly bone metastatic castration-resistant prostate cancer patient: a case report presentation and comparison with existing literature.
Aging Clin Exp Res
; 30(6): 677-680, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28856577
14.
Artificial Intelligence in Clinical Oncology: From Data to Digital Pathology and Treatment.
Am Soc Clin Oncol Educ Book
; 43: e390084, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37235822
15.
Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4).
J Thorac Oncol
; 18(8): 1031-1041, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36958688
16.
Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell Lung Cancer With Novel Driver Alterations.
Clin Lung Cancer
; 24(7): 631-640.e2, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37775370
17.
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors.
Lung Cancer
; 186: 107417, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37918061
18.
Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry.
JTO Clin Res Rep
; 4(1): 100433, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36793384
19.
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines.
J Thorac Oncol
; 18(8): 1070-1081, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37094664
20.
The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy.
Clin Lung Cancer
; 24(4): 381-387, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36959048